Contrast-enhanced mammography for extra findings on breast MRI
Part of Cancer, Skin clinical trials.
This study tests whether a special type of mammogram, called contrast-enhanced mammography (CEM), can better spot additional breast abnormalities that were seen on your MRI. It might help doctors decide on the best next steps without needing more invasive tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old
- You were referred to the breast clinic within the last 30 days for a suspicious breast finding
- You have a breast MRI from within the last 14 days that shows extra areas of concern
- You have not had any breast biopsy or surgery for this condition
- You are not receiving chemotherapy, hormone therapy, or radiation therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether contrast-enhanced mammography (a special mammogram with a dye injection) can help find breast cancers in women who have had breast cancer before and have dense breasts. You would get this test in addition to your normal screening, and it may offer better detection than ultrasound alone.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This study tests how well a special mammogram with contrast can help assess breast cancer risk in women with dense breast tissue. It may help improve screening planning, especially when standard mammograms are harder to read due to density.
This study is testing whether adding an MRI to a normal mammogram can find more cancers in women with dense breasts. If you participate, you may benefit from extra monitoring and peace of mind.
This study compares two ways of imaging the breast—molecular breast imaging (a scan that uses a small radioactive tracer) and standard breast MRI—to better find or rule out breast cancer. You may join if you are considered high risk and already have a breast MRI planned, and you can do both tests close together.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.